ArchiMed-backed NAMSA buys Syntactx

NAMSA, which is backed by ArchiMed, has acquired New York City-based Syntactx, a contract research organization focused on end-to-end services for medical devices.

5 January 2021•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles